Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1648715, 9 pages
https://doi.org/10.1155/2017/1648715
Research Article

Fibroblast Growth Factor 21 Promotes C2C12 Cells Myogenic Differentiation by Enhancing Cell Cycle Exit

1Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of the Ministry of Education and Key Laboratory of Swine Genetics and Breeding of the Ministry of Agriculture, Huazhong Agricultural University, Wuhan 430070, China
2The Cooperative Innovation Center for Sustainable Pig Production, Wuhan 430070, China

Correspondence should be addressed to Xinyun Li; nc.ude.uazh.liam@ilyx

Received 12 May 2017; Revised 30 July 2017; Accepted 6 August 2017; Published 4 October 2017

Academic Editor: Pere Domingo

Copyright © 2017 Xinyi Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Nishimura, Y. Nakatake, M. Konishi, and N. Itoh, “Identification of a novel FGF, FGF-21, preferentially expressed in the liver,” Biochimica et Biophysica Acta: Gene Structure and Expression, vol. 1492, no. 1, pp. 203–206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kharitonenkov, T. L. Shiyanova, A. Koester et al., “FGF-21 as a novel metabolic regulator,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1627–1635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Itoh and D. M. Ornitz, “Evolution of the Fgf and Fgfr gene families,” Trends in Genetics, vol. 20, no. 11, pp. 563–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Ogawa, H. Kurosu, M. Yamamoto et al., “BetaKlotho is required for metabolic activity of fibroblast growth factor 21,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 18, pp. 7432–7437, 2007. View at Google Scholar
  5. X. Ding, J. Boney-Montoya, B. M. Owen et al., “βKslotho is required for fibroblast growth factor 21 effects on growth and metabolism,” Cell Metabolism, vol. 16, no. 3, pp. 387–393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. C. Adams, C. Yang, T. Coskun et al., “The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue,” Molecular Metabolism, vol. 2, no. 1, pp. 31–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ye, W. Lu, X. Wang et al., “FGF21-FGFR1 coordinates phospholipid homeostasis, lipid droplet function, and ER stress in obesity,” Endocrinology, vol. 157, no. 12, pp. 4754–4769, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Muise, B. Azzolina, D. W. Kuo et al., “Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor γ and altered metabolic states,” Molecular Pharmacology, vol. 74, no. 2, pp. 403–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. Samms, M. J. Fowler, S. Cooper et al., “Photoperiodic regulation of FGF21 production in the Siberian hamster,” Hormones and Behavior, vol. 66, no. 1, pp. 180–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Solon-Biet, V. C. Cogger, T. Pulpitel et al., “Defining the Nutritional and Metabolic Context of FGF21 Using the Geometric Framework,” Cell Metabolism, vol. 24, no. 4, pp. 555–565, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. M. K. Brahma, R. C. Adam, N. M. Pollak et al., “Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis,” Journal of Lipid Research, vol. 55, no. 11, pp. 2229–2241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Izumiya, H. A. Bina, N. Ouchi, Y. Akasaki, A. Kharitonenkov, and K. Walsh, “FGF21 is an Akt-regulated myokine,” FEBS Letters, vol. 582, no. 27, pp. 3805–3810, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. K. Badman, P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier, “Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states,” Cell Metabolism, vol. 5, no. 6, pp. 426–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Lundåsen, M. C. Hunt, L.-M. Nilsson et al., “PPARα is a key regulator of hepatic FGF21,” Biochemical and Biophysical Research Communications, vol. 360, no. 2, pp. 437–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Hondares, R. Iglesias, A. Giralt et al., “Thermogenic activation induces FGF21 expression and release in brown adipose tissue,” Journal of Biological Chemistry, vol. 286, no. 15, pp. 12983–12990, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Bobbert, F. Schwarz, A. Fischer-Rosinsky et al., “Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians,” Diabetes Care, vol. 36, no. 1, pp. 145–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. F. L. Mashili, R. L. Austin, A. S. Deshmukh et al., “Direct effects of FGF21 on glucose uptake in human skeletal muscle: Implications for type 2 diabetes and obesity,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 3, pp. 286–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Gallego-Escuredo, J. Gómez-Ambrosi, V. Catalan et al., “Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients,” International Journal of Obesity, vol. 39, no. 1, pp. 121–129, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. F. M. Fisher, P. C. Chui, P. J. Antonellis et al., “Obesity is a fibroblast growth factor 21 (FGF21)-resistant state,” Diabetes, vol. 59, no. 11, pp. 2781–2789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. R. Markan, M. C. Naber, S. M. Small, L. Peltekian, R. L. Kessler, and M. J. Potthoff, “FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue,” Molecular Metabolism, vol. 6, no. 6, pp. 602–610, 2017. View at Publisher · View at Google Scholar
  21. R. Kruse, S. G. Vienberg, B. F. Vind, B. Andersen, and K. Højlund, “Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes,” Diabetologia, vol. 60, no. 10, pp. 2042–2051, 2017. View at Publisher · View at Google Scholar
  22. Y. Wang, X. Liu, L. Hou, W. Wu, S. Zhao, and Y. Xiong, “Fibroblast growth factor 21 suppresses adipogenesis in pig intramuscular fat cells,” International Journal of Molecular Sciences, vol. 17, no. 1, article no. 11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Coskun, H. A. Bina, M. A. Schneider et al., “Fibroblast growth factor 21 corrects obesity in mice,” Endocrinology, vol. 149, no. 12, pp. 6018–6027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Xu, D. J. Lloyd, C. Hale et al., “Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice,” Diabetes, vol. 58, no. 1, pp. 250–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kharitonenkov and R. DiMarchi, “Fibroblast growth factor 21 night watch: advances and uncertainties in the field,” Journal of Internal Medicine, vol. 281, no. 3, pp. 233–246, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Planavila, I. Redondo, E. Hondares et al., “Fibroblast growth factor 21 protects against cardiac hypertrophy in mice,” Nature Communications, vol. 4, article 2019, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Zhang, Z. Huang, J. Gu et al., “Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway,” Diabetologia, vol. 58, no. 8, pp. 1937–1948, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Cuevas-Ramos, P. Almeda-Valdés, C. E. Meza-Arana et al., “Exercise increases serum fibroblast growth factor 21 (FGF21) levels,” PLoS ONE, vol. 7, no. 5, Article ID e38022, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. H. Kim, S. H. Kim, Y.-K. Min, H.-M. Yang, J.-B. Lee, and M.-S. Lee, “Acute exercise induces FGF21 expression in mice and in healthy humans,” PLoS ONE, vol. 8, no. 5, Article ID e63517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Hojman, M. Pedersen, A. R. Nielsen et al., “Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia,” Diabetes, vol. 58, no. 12, pp. 2797–2801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Tanimura, W. Aoi, Y. Takanami et al., “Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation,” Physiological Reports, vol. 4, article e12828, no. 12, 2016. View at Publisher · View at Google Scholar
  32. F. Ribas, J. Villarroya, H. Elayne, M. Giralt, and F. Villarroya, “FGF21 expression and release in muscle cells: Involvement of MyoD and regulation by mitochondria-driven signalling,” Biochemical Journal, vol. 463, no. 2, pp. 191–199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Liu, Y. Wang, L. Hou, Y. Xiong, and S. Zhao, “Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21-SIRT1-AMPK-PGC1α Pathway,” Journal of Cellular Physiology, vol. 232, no. 7, pp. 1893–1906, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Li, Y. Li, Y. Duan, C.-A. A. Hu, Y. Tang, and Y. Yin, “Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue,” Cytokine and Growth Factor Reviews, vol. 33, pp. 73–82, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Keipert, M. Ost, K. Johann et al., “Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine,” American Journal of Physiology - Endocrinology and Metabolism, vol. 306, no. 5, pp. E469–E482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Kwon, S. M. O'Dwyer, R. K. Baker, S. D. Covey, and T. J. Kieffer, “FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1,” Cell Reports, vol. 13, no. 8, pp. 1521–1527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Ji, J. Zheng, J. Lv et al., “Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway,” Free Radical Biology and Medicine, vol. 84, pp. 161–170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Potthoff, T. Inagaki, S. Satapati et al., “FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 26, pp. 10853–10858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Vandanmagsar, J. D. Warfel, S. E. Wicks et al., “Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle,” Cell Reports, vol. 15, no. 8, pp. 1686–1699, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Casteras, A. Abdul-Wahed, M. Soty et al., “The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice,” Diabetologia, vol. 59, no. 12, pp. 2645–2653, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Mendelsohn and J. W. Larrick, “Fibroblast growth factor-21 is a promising dietary restriction mimetic,” Rejuvenation Research, vol. 15, no. 6, pp. 624–628, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Salminen, A. Kauppinen, and K. Kaarniranta, “FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process,” Journal of Molecular Medicine, vol. 95, no. 2, pp. 123–131, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. L. A. Buttitta and B. A. Edgar, “Mechanisms controlling cell cycle exit upon terminal differentiation,” Current Opinion in Cell Biology, vol. 19, no. 6, pp. 697–704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Jahn, J.-I. Sadoshima, and S. Izumo, “Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells,” Experimental Cell Research, vol. 212, no. 2, pp. 297–307, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. S. X. Skapek, J. Rhee, D. B. Spicer, and A. B. Lassar, “Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase,” Science, vol. 267, no. 5200, pp. 1022–1024, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Sin, A. M. Andres, D. J. R. Taylo R et al., “Mitophagy is required for mitochondrial biogenesis and myogenic differentiation of C2C12 myoblasts,” Autophagy, vol. 12, no. 2, pp. 369–380, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Barbieri, M. Guescini, C. Calcabrini et al., “Creatine Prevents the Structural and Functional Damage to Mitochondria in Myogenic, Oxidatively Stressed C2C12 Cells and Restores Their Differentiation Capacity,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 5152029, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. M. S. Lee, S.-E. Choi, E. S. Ha et al., “Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB,” Metabolism: Clinical and Experimental, vol. 61, no. 8, pp. 1142–1151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Ding, J. Boney-Montoya, B. Owen et al., “βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism,” Cell Metabolism, vol. 16, no. 3, pp. 387–393, 2012. View at Publisher · View at Google Scholar
  50. K. F. Tacer, A. L. Bookout, X. Ding et al., “Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse,” Molecular Endocrinology, vol. 24, no. 10, pp. 2050–2064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Suzuki, Y. Uehara, K. Motomura-Matsuzaka et al., “βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c,” Molecular Endocrinology, vol. 22, no. 4, pp. 1006–1014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Luo and W. L. McKeehan, “Stressed liver and muscle call on adipocytes with FGF21,” Frontiers in Endocrinology, vol. 4, Article ID Article 194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Y. Jeon, S.-E. Choi, E. S. Ha et al., “Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles,” Endocrine, vol. 53, no. 1, pp. 97–106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. K.-I. Tomiyama, R. Maeda, I. Urakawa et al., “Relevant use of Klotho in FGF19 subfamily signaling system in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1666–1671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. G. Georgakilas, O. A. Martin, and W. M. Bonner, “p21: A Two-Faced Genome Guardian,” Trends in Molecular Medicine, vol. 23, no. 4, pp. 310–319, 2017. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Hydbring, M. Malumbres, and P. Sicinski, “Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases,” Nature Reviews Molecular Cell Biology, vol. 17, no. 5, pp. 280–292, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Karimian, Y. Ahmadi, and B. Yousefi, “Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage,” DNA Repair, vol. 42, pp. 63–71, 2016. View at Publisher · View at Google Scholar · View at Scopus